Lilly to seek first approval of an autoimmune drug for hair loss

Eli Lilly’s autoimmune disease drug baricitinib spurred hair regrowth in patients with a severe form of alopecia areata in a second Phase 3 study, positioning the drug to become the first treatment specifically approved for the disease.